Nanomaterials-enriched sensors for detection of chiral pharmaceuticals.


Journal

Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336

Informations de publication

Date de publication:
30 Nov 2022
Historique:
received: 04 06 2022
revised: 02 09 2022
accepted: 04 09 2022
pubmed: 18 9 2022
medline: 14 10 2022
entrez: 17 9 2022
Statut: ppublish

Résumé

Advancements in nanoscience and nanotechnology have opened new pathways to fabricate novel nanostructures with interesting properties that would be used for different applications. In this respect, nanostructures comprising chirality are one of the most rapidly developing research fields encompassing chemistry, physics and biology. Chirality, also known as mirror asymmetry, describes the geometrical property of an object that is not superimposable on its mirror image. This characteristic plays a crucial role because these identical forms of chiral species in pharmaceuticals or food additives may exhibit different effects on living organisms. Therefore, chiral analysis is an important field of modern chemical analysis in health-related industries that are reliant on the production of enantiomeric compounds involving pharmaceuticals. This review covers the recent advances dealing with the synthesis, design and advantageous analytical performance of nanomaterials-enriched sensors used for chiral pharmaceuticals. We conclude this review with the challenges existing in this research field and our perspectives on some potential strategies with cutting-edge approaches for the rational design of sensors for chiral pharmaceuticals. We expect this comprehensive review will inspire future studies in nanomaterials-enriched chiral sensors.

Identifiants

pubmed: 36115205
pii: S0731-7085(22)00452-6
doi: 10.1016/j.jpba.2022.115031
pii:
doi:

Substances chimiques

Food Additives 0
Pharmaceutical Preparations 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

115031

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eda Gumus (E)

Biomaterials and Biotechnology Laboratory, Science and Technology Research and Application Center (BITAM), Necmettin Erbakan University, 42140 Konya, Turkey.

Haluk Bingol (H)

Biomaterials and Biotechnology Laboratory, Science and Technology Research and Application Center (BITAM), Necmettin Erbakan University, 42140 Konya, Turkey; Department of Chemistry Education, A.K. Education Faculty, Necmettin Erbakan University, 42090 Konya, Turkey.

Erhan Zor (E)

Biomaterials and Biotechnology Laboratory, Science and Technology Research and Application Center (BITAM), Necmettin Erbakan University, 42140 Konya, Turkey; Department of Science Education, A.K. Education Faculty, Necmettin Erbakan University, 42090 Konya, Turkey. Electronic address: zorerhan@gmail.com.

Articles similaires

Humans Pharmaceutical Preparations Drug Utilization Prescription Drugs
Risk Assessment Plant Leaves Isomerism Humans Stereoisomerism
Colorimetry Captopril Humans Alloys Limit of Detection
Colorimetry Hydrogen Peroxide Nanostructures Limit of Detection Benzidines

Classifications MeSH